Loading...
•
Jun 30, 2022
Stem Q2 2022 Earnings Report
Stem's Q2 2022 financial results were announced, with revenue exceeding guidance, margins aligning with expectations, and bookings and CARR guidance raised for FY 2022.
Key Takeaways
Stem, Inc. reported Q2 2022 revenue of $67 million, a 246% increase year-over-year. The company's contracted backlog nearly tripled compared to the previous year, driven by $226 million in bookings. Stem is raising its full-year 2022 bookings and CARR guidance while reiterating its full-year revenue and adjusted EBITDA guidance.
Revenue of $67 million, up 246% year-over-year.
GAAP Gross Margin of 12%, up from (1)% in Q2 2021.
Bookings of $226 million, up 402% year-over-year.
Contracted backlog of $727 million, up 191% year-over-year.
Stem
Stem
Forward Guidance
The Company is updating its full-year 2022 financial and operational guidance. Revenue is unchanged. Non-GAAP Gross Margin (%) is unchanged. Adjusted EBITDA is unchanged. Bookings updated to $775 - $950 millions. CARR (year-end) updated to $65 - $85 millions.
Positive Outlook
- Revenue unchanged at $350 - $425 million.
- Non-GAAP Gross Margin unchanged at 15% - 20%.
- Adjusted EBITDA unchanged at $(60) - $(20) million.
- Bookings updated to $775 - $950 million from $650 - $750 million.
- CARR (year-end) updated to $65 - $85 million from $60 - $80 million.
Challenges Ahead
- Supply chain constraints.
- Permitting and interconnection delays.
- Certain regulatory actions.
- COVID-19 and its recent subvariants.
- General economic, geopolitical, and business conditions, including the ongoing conflict between Russia and Ukraine.